James B. Tananbaum - Dec 23, 2021 Form 4/A - Amendment Insider Report for PARDES BIOSCIENCES, INC. (PRDS)

Role
Director, 10%+ Owner
Signature
/s/ Elizabeth Lacy, Attorney-in-Fact for James B. Tananbaum
Stock symbol
PRDS
Transactions as of
Dec 23, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/10/2022, 04:17 PM
Date Of Original Report
Dec 28, 2021
Previous filing
Dec 23, 2021
Next filing
Jun 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRDS Stock Option (right to buy) Award $0 +75K $0.00 75K Dec 23, 2021 Common Stock 75K $9.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in substantially equal monthly installments over three years, subject to a continued service relationship. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2021 Stock Option and Incentive Plan with the U.S. Securities and Exchange Commission.

Remarks:

This amendment amends the Form 4 filed on December 28, 2021 solely to correct Table II, Column 5 which inadvertently reported the 75,000 stock options as having been "Disposed" as opposed to the correct designation of "Acquired."